Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 17;91(1):89–100. doi: 10.1002/ana.26251

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Violin plot illustrating anti‐SARS‐CoV2 antibody response following complete COVID‐19 vaccine course, according to vaccine type. The plot shows distribution of results according to tertiles, using the “no DMT” group as a reference. The circle indicates median, and the bold line indicates interquartile range. Astra Zeneca: ChAdOx1 nCoV‐19 (Oxford–AstraZeneca), Pfizer: BNT162b2 mRNA (Pfizer‐BioNTech) vaccine. (a) People who had received anti‐CD20 monoclonal antibodies. (b) All other DMT (fingolimod excluded). COVID‐19 = coronavirus disease 2019; DMT = disease modifying therapy; nCov = novel coronavirus; SARS‐CoV‐2 = severe acute respiratory syndrome‐coronavirus 2. [Color figure can be viewed at www.annalsofneurology.org]